BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32065117)

  • 1. Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α.
    Xu W; Wang Z; Li K; Jin R
    Med Sci Monit; 2020 Feb; 26():e921649. PubMed ID: 32065117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph
    Xu WF; Wang ZJ; Li K; Shen YQ; Lu K; Lv XY; Wen YX; Jin RM
    Curr Med Sci; 2020 Apr; 40(2):354-362. PubMed ID: 32337697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huang Qi Huai Granules Induce Apoptosis in Acute Lymphoblastic Leukemia Cells through the Akt/FoxO1 Pathway.
    Han J; Lin M; Zhou D; Zhang Z; Jin R; Zhou F
    Cell Physiol Biochem; 2016; 38(5):1803-14. PubMed ID: 27160160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM.
    Rambal AA; Panaguiton ZL; Kramer L; Grant S; Harada H
    Leukemia; 2009 Oct; 23(10):1744-54. PubMed ID: 19404317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
    Wang XW; Xu YH
    Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.
    Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D
    Haematologica; 2007 Nov; 92(11):1460-9. PubMed ID: 18024393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.
    Dixon ZA; Nicholson L; Zeppetzauer M; Matheson E; Sinclair P; Harrison CJ; Irving JA
    Haematologica; 2017 Apr; 102(4):736-745. PubMed ID: 27979926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production.
    Abdoul-Azize S; Buquet C; Vannier JP; Dubus I
    Eur J Pharmacol; 2016 Aug; 784():90-8. PubMed ID: 27179991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
    Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of EPA on Hsp90 and GRα protein expression in multiple myeloma drug-resistant cells.
    Wu S; Chen Y; Wang X; Weng S; Zhou W; Liu Z
    BMC Cancer; 2021 Oct; 21(1):1076. PubMed ID: 34600510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells.
    Sudsaward S; Khunchai S; Thepmalee C; Othman A; Limjindaporn T; Yenchitsomanus PT; Mutti L; Krstic-Demonacos M; Demonacos C
    Int J Oncol; 2020 Sep; 57(3):835-844. PubMed ID: 32705154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
    Bongiovanni D; Tosello V; Saccomani V; Dalla Santa S; Amadori A; Zanovello P; Piovan E
    Oncogene; 2020 Oct; 39(42):6544-6555. PubMed ID: 32917954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
    Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
    Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.
    Bachmann PS; Gorman R; Mackenzie KL; Lutze-Mann L; Lock RB
    Blood; 2005 Mar; 105(6):2519-26. PubMed ID: 15572593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
    Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.